CompletedNot Applicable

Development and Validation of a Therapeutic Decision Aid in Ectopic Pregnancy: GEUDECID Study

France109 participantsStarted 2023-10-22

Plain-language summary

The aim's study is to validate a therapeutic aid in women with a less active ectopic pregnancy. A prospective recrutement of 100 women will be performed in 16 different hospitals in France. The decision aid will be used and a questionnaire about its usefulness, comprehension and satisfaction will be given to women and doctors.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women who speak and read french * Not opposed to participate to the research * With a tubal ectopic pregnancy visible at sonography * with an HCG rate under 10 000UI/ml Exclusion Criteria: * Cardiac activity present in the embryo * Hemoperitoin * Hemodynamic instability * Spontaneous pelvic pain * Contre indication to methotrexate * Protected adult patient

What they're measuring

Validate acceptability of the therapeutic decision tool in women managed for less active ectopic tubal pregnancy.

Timeframe: One day

Trial details

NCT IDNCT05745831

SponsorInstitut National de la Santé Et de la Recherche Médicale, France

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2024-04-22

View on ClinicalTrials.gov More To Validate a Decision Aid for Ectopic Pregnancy trials